The waiting is the hardest part: The Tipline for 3 October 2017

Today’s briefing is heavier than usual on California, but the feds are busy too. In addition to putting an early end to the waiting period for more than a dozen deals, the US antitrust agencies settled another merger with remedies and continue to litigate against drugmakers.

Get unlimited access to all Global Competition Review content